Apollomics to participate in a fireside chat at the h.c. wainwright 4th annual precision oncology virtual conference

Foster city, calif., nov. 29, 2023 (globe newswire) -- apollomics inc. (“apollomics” or the “company”), a clinical-stage biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, today announced that guo-liang yu, ph.d., co-founder and chief executive officer of apollomics and sanjeev redkar, ph.d., co-founder and president, will participate in a fireside chat at the h.c. wainwright 4th annual precision oncology virtual conference on wednesday, december 6, 2023 at 11:30 a.m. et.
APLM Ratings Summary
APLM Quant Ranking